老年痴呆患者血浆β-内啡肽浓度的变化及意义

发布时间：2018-05-27 05:22

  本文选题：老年痴呆 + β-内啡肽　； 参考：《中国老年学杂志》2017年17期

【摘要】：目的观察老年痴呆患者血浆β-内啡肽浓度的变化及意义。方法将确诊为老年痴呆的24例患者随机分为治疗组和对照组,每组12例。治疗组使用免疫治疗,对照组采用空白对照。观察两组人群2个月内血浆β-内啡肽浓度变化。结果治疗前治疗组和对照组血浆β-内啡肽水平无统计学差异(P0.05)。经过2个月的治疗,治疗组血浆β-内啡肽水平显著低于对照组(P0.05),治疗组6例患者病情有所减轻。结论降低老年痴呆患者血浆β-内啡肽水平可以改善其病情。
[Abstract]:Objective to observe the change and significance of plasma 尾-endorphin in senile dementia patients. Methods 24 patients with Alzheimer's disease were randomly divided into treatment group and control group with 12 cases in each group. Immunotherapy was used in the treatment group and blank control was used in the control group. The changes of plasma 尾-endorphin in two groups were observed within 2 months. Results there was no significant difference in plasma 尾-endorphin levels between the treatment group and the control group before treatment (P 0.05). After 2 months of treatment, the plasma 尾 -endorphin level in the treatment group was significantly lower than that in the control group (P 0.05). Conclusion reducing plasma 尾-endorphin level can improve dementia patients' condition.
【作者单位】： 贵阳中医学院;
【分类号】：R749.16
，

本文编号：1940619